The 10th symposium on children and adolescents with perinatal HIV exposure Session 3 - Research to inform the care agenda for children and adolescents with perinatal HIV exposure

Over the past decade, we have convened international meetings alongside International AIDS Society conferences. This is to identify opportunities to inform health policy and programming to ensure that children with perinatal HIV exposure thrive to their fullest potential. Globally, there are now over 16 million children under 15 years of age who were exposed to HIV in utero, at birth and during breastfeeding. When a child is born HIV-free, it does not guarantee that they will thrive in a similar way to a child born to a woman who is not living with HIV. Research has shown increased vulnerability to infectious morbidity and mortality, poorer growth and neurodevelopmental deficits compared with children not exposed to HIV. Risk of health disparities and opportunities for resilience include biological, social and structural aetiologies. For the 10th Symposium on Children and Adolescents with Perinatal HIV Exposure, we will hold a pre-conference involving dialogue and presentations from families and adolescents affected by HIV, policy makers, clinicians and researchers. Presentations will span infancy through adolescence.

This session is the third out of three sessions part of the 10th symposium on children and adolescents with perinatal HIV exposure pre-conference. Watch session 1 here and session 2 here.

21 July 2024
English
Chair
Renata Sanders

Renata Sanders

Children’s Hospital of Philadelphia

Speakers
Renata Sanders

Renata Sanders

Children’s Hospital of Philadelphia

Session outline
Renata Sanders

Renata Sanders

Children’s Hospital of Philadelphia

Amara Ezeamama

Michigan State University

Helena Nangombe

YWEN

Daddicky Sauyere

Daddicky Sauyere

-

Panel discussion

Michelle Bulterys

University of Washington

Father engagement and caregiver relationship dynamics impact early child neurodevelopment

Fatima Kakkar

Université de Montréal

Inadequate serologic response following vaccination against Hepatitis B virus in children who were exposed to HIV

Renata Sanders

Children's Hospital of Philadelphia

Michelle Bulterys

University of Washington

Fatima Kakkar

Fatima Kakkar

CHU Sainte-Justine, University of Montreal

Q&A
Shaffiq Essajee

Shaffiq Essajee

UNICEF

Research, programming and implementation gaps on children and adolescents with perinatal HIV exposure

Sonia Lee

NIH

Closing remarks